U.S. Supreme Court rejects Allergan bid to use tribe to shield drug patents
The U.S. Supreme Court on Monday cast aside pharmaceutical company Allergan Plc's unorthodox bid to shield patents from a federal administrative court's review by transferring them to a Native American tribe.
No comments:
Post a Comment